Life Science Success copertina

Life Science Success

Life Science Success

Di: Don Davis PhD MBA
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
A proposito di questo titolo

On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.

© 2026 Life Science Success
Economia Marketing Marketing e vendite Scienza Scienze biologiche
  • Adam Walker on Biometrics and the Human Side of Clinical Trials
    Nov 12 2026

    Send us Fan Mail

    In this episode of the Life Science Success Podcast my guest is Adam Walker. Adam is a biometrics consultant and the host of the Pharma Prescribed Podcast, where he has the conversations the life sciences industry rarely makes time for.


    00:00 Show Introduction
    00:34 Meet Adam Walker
    01:07 Origin Story
    03:25 Biometrics Explained
    06:49 Data Quality Pitfalls
    08:11 Rare Disease Challenges
    10:11 Decentralized Trials Reality
    14:04 Why Pharma Prescribed
    17:32 Podcasting Craft
    20:27 Sponsor Message
    21:16 Truth and Vulnerability
    25:26 Lessons From Interviews
    30:25 AI Hype vs Reality
    40:11 Operational Bottlenecks
    41:12 Mental Health Focus
    46:09 Quickfire Reflections
    48:42 Where To Connect
    52:39 Closing Outro

    Mostra di più Mostra meno
    53 min
  • Gregory Glover on Regulatory IP and the Fight for Market Exclusivity
    Nov 12 2026

    Send us Fan Mail

    In this episode of the Life Science Success Podcast my guest is Dr. Gregory Glover, founder of the Pharmaceutical Law Group, a Washington, DC practice built at the intersection of FDA regulation and intellectual property.

    00:00 Show Introduction
    00:29 Meet Gregory Glover
    01:15 Doctor to Lawyer Journey
    03:00 Why Medical Training Helps
    04:07 Hatch-Waxman Origins
    08:13 Exclusivity Versus Patents
    11:48 Where Hatch-Waxman Ages
    14:21 Skinny Label Explained
    20:23 Aligning Strategy Early
    25:06 Sponsor Break
    26:19 When to Start Lifecycle
    27:51 What Competitors Can See
    29:20 Lifecycle Management Basics
    31:29 Manufacturing and Patents
    33:22 Overlooked Exclusivity Plays
    35:06 BPCIA and Biosimilars
    38:09 Policy Misunderstandings
    39:27 Who Greg Works With
    40:27 Barriers to Maximizing IP
    43:07 Funding Climate Effects
    45:13 Rapid Fire Reflections
    48:51 How to Reach Greg
    49:27 Closing and Subscribe

    Mostra di più Mostra meno
    50 min
  • Beyond the Pilot: Where AI Actually Works in Life Sciences
    Nov 3 2026

    Send us Fan Mail

    Everyone’s talking about AI in life sciences, but how much of it is actually running in production, and how much is still a pilot that never quite launched?

    On this episode of Life Science Success, we brought together four people who are doing the work, not just talking about it:

    • Josh Bersin, Founder & CEO, The Josh Bersin Company
    • Michelle Bridenbaker, Global Head of Medical Excellence & Communications, Recordati
    • Janik Jaskolski, CEO & Co-founder, Semalytix
    • Beena Wood, Chief Product Officer, Qinecsa

    They’re refreshingly honest about it. Michelle talks about her “epic fail” of a chatbot with IBM Watson over a decade ago, and how it took years of trial and error before AI started paying off for her team. Beena describes LLM-written safety narratives that sounded perfect but described pregnant male patients, and explains why she calls today’s state of the industry “Schrödinger’s AI.” Janik shares how his team listens to patients across 26 languages and turns those conversations into evidence pharma can actually use. And Josh makes the case that AI won’t replace your job, but it will change what your job looks like.

    You’ll also hear how each of them decides what AI should handle and what has to stay with a human, why you can’t just bolt AI onto a broken process, and what they expect to see by 2030.

    If you work in pharma, biotech or anywhere in the regulated side of healthcare and you’re trying to separate hype from reality, this one’s for you.

    Chapters:

    00:00 Show Intro
    00:30 Panel Setup: AI Through 2030
    01:19 Patient Data and AI Value
    03:56 AI in Drug Safety
    07:42 Medical Affairs AI Wins
    11:35 Workforce and Jobs Shift
    15:47 Product Deep Dives Begin
    16:02 Semalytix Atlas Explained
    20:20 PV Trust and Governance
    25:11 MedInfo Use Case Framework
    30:50 Galileo, Jupiter and Trusted HR AI
    34:41 Specialist Agent Networks
    35:44 Sponsor Break
    36:39 Platforms vs. Point Solutions
    38:50 Market Segmentation Strategy
    42:28 Human-Led Automation
    47:20 PV Governance Framework
    50:57 Future of Agent Workforces
    52:46 2030 Outlook: Medical Affairs
    54:23 Safety Intelligence Vision
    56:21 Company Second Brains
    59:03 Where to Find Panelists
    01:02:20 Final Thanks and Sign-Off

    Connect with our guests:

    • Josh Bersin: joshbersin.com (and check out his new book, Superpowered)
    • Michelle Bridenbaker: find her on LinkedIn, and follow Medical Information Leaders in Europe there too
    • Janik Jaskolski: semalytix.com
    • Beena Wood: qinecsa.com

    Thanks to our sponsor, Life Science Wealth, a wealth management firm that works only with life science professionals. Book a free consultation at lifesciencewealth.com.

    Mostra di più Mostra meno
    1 ora e 3 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione